# US 2024/0198105 A1 · Methods for stimulation of cranial nerves

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198105 A1
- Document ID: US20240198105A1
- Status: Published application
- Kind: A1
- Application number: 18/397,066
- Filed: 2023-12-27
- Published: 2024-06-20
- Earliest claimed: 2020-01-10
- Assignees: NuXcel2, L.L.C.
- Applicants: NuXcel2, L.L.C.
- Inventors: Lynn Elliott; Stephen C. Masson, JR.
- Web page: https://patentgrep.com/patent/US20240198105A1

## CPC

- A61N 1/3611: {Respiration control (stimulating respiratory organs A61N1/3601)}
- A61B 5/08: Measuring devices for evaluating the respiratory organs
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/0556: {Cuff electrodes}
- A61N 1/36125: {Details of circuitry or electric components}
- A61N 1/37518: {Anchoring of the implants, e.g. fixation}
- A61B 5/11: Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb {(A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721)}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61N 1/36078: {Inducing or controlling sleep or relaxation (non-implantable stimulator A61M21/00)}
- A61N 1/37229: {Shape or location of the implanted or external antenna}
- A61N 1/375: Constructional arrangements, e.g. casings
- A61N 1/3787: {from an external energy source}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Neuromodulation of cranial nerves can be used to treat sleep or breathing disorders, among other diseases and disorders. A neuromodulation system can include a housing configured for implantation in an anterior cervical region of a patient, such as at or under a mandible of the patient, such as at least partially in one or more of a submental triangle, a submandibular triangle, and a carotid triangle. The system can include an electrode lead coupled to the housing, and the electrode lead can include an electrode configured to be disposed at or near a cranial nerve target in the patient. The system can be configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the electrode.

## Claims

### Claim 1

(canceled)

### Claim 2

A system comprising:
an implantable neuromodulation device housing configured for implantation in an anterior cervical region of a patient between a mylohyoid muscle of the patient and a digastric muscle of the patient;
a power storage circuit disposed inside the device housing;
a first physiologic status sensor coupled to a processor circuit;
a signal generator circuit disposed inside the device housing and configured to use power from the power storage circuit to generate a neurostimulation therapy signal, wherein characteristics of the neurostimulation therapy signal are based on instructions received from the processor circuit; and
a first electrode lead coupled to the signal generator circuit, wherein the first electrode lead includes a therapy delivery electrode configured to provide the neurostimulation therapy signal at or near a first cranial nerve target in the patient.

### Claim 3 (depends on 2)

The system of claim 2, wherein the processor circuit is configured to update one or more characteristics of the neurostimulation therapy signal based on information received from the first physiologic status sensor.

### Claim 4 (depends on 3)

The system of claim 3, wherein the one or more characteristics of the neurostimulation therapy signal include a pulse amplitude, pulse duration, waveform morphology, frequency, or signal burst pattern of the neurostimulation therapy signal.

### Claim 5 (depends on 3)

The system of claim 3, wherein the first physiologic status sensor is an electrical activity sensor.

### Claim 6 (depends on 5)

The system of claim 5, wherein the electrical activity sensor is configured to sense impedance information about the patient.

### Claim 7 (depends on 5)

The system of claim 5, wherein the electrical activity sensor comprises an electrode of the first electrode lead.

### Claim 8 (depends on 5)

The system of claim 5, wherein the electrical activity sensor is configured to sense one or more of electrocardiogram information, electromyogram information, or electroneurogram information about the patient.

### Claim 9 (depends on 3)

The system of claim 3, wherein the first physiologic status sensor is an implantable sensor that includes an accelerometer or a gyroscope that is configured to sense movement, vibration, position, or orientation information about the patient.

### Claim 10 (depends on 9)

The system of claim 9, comprising a second physiologic status sensor, wherein the processor circuit is configured to update one or more characteristics of the neurostimulation therapy signal based on information received from the second physiologic status sensor and on information received from the accelerometer or gyroscope.

### Claim 11 (depends on 3)

The system of claim 3, wherein the first physiologic status sensor is an implantable chemical sensor configured to measure information about one or more chemicals inside the patient.

### Claim 12 (depends on 3)

The system of claim 3, wherein the first physiologic status sensor is an implantable plethysmography sensor.

### Claim 13 (depends on 3)

The system of claim 3, wherein the first physiologic status sensor is an implantable pressure sensor.

### Claim 14 (depends on 3)

The system of claim 3, wherein the neurostimulation therapy signal is configured to treat one or more of obstructive sleep apnea (OSA), heart failure, hypertension, epilepsy, depression, post-traumatic stress disorder (PTSD), attention deficit hyperactivity disorder (ADHD), craniofacial pain syndrome, facial palsy, migraine headaches, xerostomia, atrial fibrillation, stroke, autism, inflammatory bowel disease, chronic inflammation, chronic pain, tinnitus, rheumatoid arthritis, and fibromyalgia.

### Claim 15 (depends on 2)

The system of claim 2, wherein the instructions from the processor circuit to the signal generator circuit are based at least in part on physiologic status information about the patient received using the first physiologic status sensor.

### Claim 16 (depends on 15)

The system of claim 15, wherein the physiologic status information includes information about a respiration, heart rate, blood pressure, or neural or muscular activation of the patient.

### Claim 17 (depends on 16)

The system of claim 16, wherein the physiologic status information includes information about respiration of the patient, and wherein the neurostimulation therapy signal is configured to treat a breathing disorder or a sleep disorder of the patient.

### Claim 18 (depends on 17)

The system of claim 17, wherein the first physiologic status sensor comprises an accelerometer configured to sense the information about the respiration of the patient, and wherein the first electrode lead includes a therapy delivery electrode configured to provide the neurostimulation therapy signal at or near a hypoglossal nerve in the patient.

### Claim 19

A method comprising:
providing an implantable neurostimulation device housing in an anterior cervical region of a patient between a mylohyoid muscle of the patient and a digastric muscle of the patient;
providing a first electrode lead, coupled to a portion of the device housing and to a signal generator circuit inside the device housing, at or near a first cranial nerve target in the patient, wherein the signal generator circuit is coupled to power storage circuitry that is inside the device housing;
using at least one sensor, sensing a physiologic status-indicating signal from the patient; and
in response to information from the physiologic status-indicating signal, providing first electrical signals to the first cranial nerve target using the signal generator circuit and an electrode of the first electrode lead.

### Claim 20 (depends on 19)

The method of claim 19, wherein sensing the physiologic status-indicating signal from the patient includes sensing respiration information about the patient using an accelerometer, and wherein the first electrical signals are configured to treat a sleep disorder or breathing disorder of the patient.

### Claim 21 (depends on 19)

The method of claim 19, wherein sensing the physiologic status-indicating signal from the patient includes sensing an impedance characteristic or electrical activity information about the patient using the electrode of the first electrode lead or using a different second electrode.

### Claim 22 (depends on 19)

The method of claim 19, comprising using the signal generator circuit, generating the first electrical signals, wherein one or more of a pulse amplitude, pulse duration, waveform morphology, frequency, or signal burst pattern of the first electrical signals is based on the information from the physiologic status-indicating signal.

### Claim 23

An implantable neurostimulation device comprising:
an implantable device housing configured for implantation between a mylohyoid muscle and a digastric muscle in a submental triangular region of a patient;
a power storage circuit disposed inside the device housing;
a signal generator circuit disposed inside the device housing and configured to generate a neurostimulation therapy signal using power from the power storage circuit;
a first implantable lead comprising a first electrode, wherein the first electrode is configured for implantation at or near a first cranial nerve target, and wherein the first electrode is configured to receive the neurostimulation therapy signal from the signal generator circuit;
one or more sensors configured to sense a physiologic status-indicating signal from the patient; and
a processor circuit configured to use information from the one or more sensors to control the signal generator circuit to generate the neurostimulation therapy signal.

### Claim 24 (depends on 23)

The implantable neurostimulation device of claim 23, wherein the one or more sensors comprises an accelerometer configured to sense motion information about the patient, and wherein the neurostimulation therapy signal is configured to treat a sleep disorder or breathing disorder of the patient.

### Claim 25 (depends on 23)

The implantable neurostimulation device of claim 23, wherein the one or more sensors comprises one or more of an electrical activity sensor, a chemical sensor, a plethysmography sensor, and/or a pressure sensor.
